Nu Skin Enterprises, Inc.

NUS Consumer Defensive Household & Personal Products

Nu Skin Enterprises, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 14.3% from fiscal 2024. In the quarter to June 2026, revenue fell 17.1%, EPS fell 1,295.4%, free cash flow fell 86.1% and total debt fell 14.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

4.87 0.13 +2.74%
Market cap
$237.1M
P/E
0.0×
Fwd P/E
5.9×
Dividend yield
4.93%
F-score
7/9
Altman Z
3.78
Beneish M
−2.35
Dividend safety
70/100

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Net Income
160.20 (146.59) 8.60 104.78 147.27 191.36 173.55 121.89 129.44 143.09
Depreciation & Amortization
52.26 69.81 70.92 72.51 76.32 73.99 76.65 83.00 71.56 72.40
Non Cash Items (Other)
(62.56) 216.86 120.80 66.74 142.92 61.23 60.16 69.73 54.47 31.46
Accounts Receivable Change
10.06 (7.76) (22.68) (11.45) 20.22 (11.21) 2.75 (10.45) (0.10) 3.36
Change in inventories
11.89 30.32 (13.22) (2.97) (126.62) (31.14) 18.45 (33.37) 7.54 9.80
Accounts Payable Change
(9.11) (7.29) (10.08) 9.26 (13.28) 24.84 (7.18) (9.16) 6.83 13.44
Change in payables and accrued liability
(54.31) (27.58) (37.70) (120.83) (104.99) 87.45 (87.00) (7.43) 22.49 (33.62)
Change in other assets and liabilities
(28.13) (16.01) 2.00 (9.97) (0.25) (17.38) (59.45) (11.46) 10.33 35.35
Operating Cash Flow
80.29 111.74 118.64 108.06 141.58 379.14 177.93 202.74 302.56 275.26
Capital expenditures
(34.28) (41.58) (58.49) (59.06) (68.61) (63.82) (66.07) (70.37) (60.16) (50.22)
Net Aquisitions
193.73 — (77.27) — (18.96) (14.95) (8.07) (38.51) (31.74) (8.69)
Long-Term Investments Change (Net)
10.21 3.62 1.26 (8.02) (1.15) (0.66) 2.73 0.12 (0.06) 1.05
Other investing activities
1.00 — — 27.05 13.86 5.76 (2.32) — — 5.65
Investing cash flow
170.66 (37.96) (134.50) (67.08) (88.73) (79.43) (71.41) (108.76) (91.96) (57.86)
Repayment/Issuance of Debt (Net)
(172.24) (112.89) 96.80 25.58 38.13 (28.21) (69.45) 29.90 (36.23) 177.57
Equity Repurchase (Common, Net)
(21.95) (2.06) (8.45) (42.99) (66.56) (138.57) (3.15) (58.79) (47.29) (232.90)
Dividends Paid (Total)
(11.83) (11.93) (77.62) (77.01) (76.27) (78.39) (82.19) (80.58) (76.06) (78.44)
Other financial activities
3.62 (6.30) — (5.08) 70.95 26.98 11.41 (7.24) 15.25 (0.94)
Financing cash flow
(202.40) (133.18) 10.73 (99.50) (104.70) (245.17) (154.79) (116.71) (159.57) (134.71)
Exchange Rate Adjustment
3.20 (9.78) (3.54) (16.35) (11.24) 12.51 (3.01) (16.75) 18.13 (14.80)
Change in Cash
51.75 (69.17) (8.67) (74.87) (63.09) 67.05 (51.28) (39.49) 69.15 67.89
Beginning Cash
186.88 256.06 264.73 339.59 402.68 335.63 386.91 426.40 357.25 289.35
Ending Cash
238.63 186.88 256.06 264.73 339.59 402.68 335.63 386.91 426.40 357.25
Stock Based Compensation
24.11 14.82 15.65 12.37 23.19 24.06 9.91 26.61 19.31 8.89
Dividends Paid (Common)
(11.83) (11.93) (77.62) (77.01) (76.27) (78.39) (82.19) (80.58) (76.06) (78.44)
Net Cash/Marketcap
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
(69.62) (28.33) (81.68) (135.96) (224.92) 52.56 (132.43) (71.88) 47.09 28.32
Investments Change (Net)
10.21 3.62 1.26 (8.02) (1.15) (0.66) 2.73 0.12 (0.06) 1.05
Issuance/Purchase of Shares
(21.95) (2.06) (8.45) (42.99) (66.56) (138.57) (3.15) (58.79) (47.29) (232.90)
Other line items
Revenue per Employee
0.53 0.56 0.53 0.59 0.59 0.52 0.49 0.55 0.48 0.47

Fold the line items

In millions of $ except per-share values · columns are period end dates